Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Therapie|May 1, 1995
[Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: a survey of 1072 French general practitioners]J Coste, C Hanotin, E LeuteneggerPhysiology & Behavior|March 15, 2000
Modalities of the food intake-reducing effect of sibutramine in humansD Chapelot, C Marmonier, F Thomas, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 3, 1998
Efficacy and tolerability of sibutramine in obese patients: a dose-ranging studyC Hanotin, F Thomas, S P Jones, et al.Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 16, 2013
Two-state model to describe the rheological behavior of vibrated granular matterPh Marchal, C Hanotin, L J Michot, et al.Obesity Research|August 4, 1998
A comparison of sibutramine and dexfenfluramine in the treatment of obesityC Hanotin, F Thomas, S P Jones, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 14, 2012
Efficacy of rimonabant in obese patients with binge eating disorderZ Pataky, C Gasteyger, O Ziegler, et al.The American Journal of Medicine|May 7, 1999
Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramineM Apfelbaum, P Vague, O Ziegler, et al.Physical Review Letters|September 26, 2012
Vibration-induced liquefaction of granular suspensionsC Hanotin, S Kiesgen de Richter, P Marchal, et al.The European Physical Journal. E, Soft Matter|July 13, 2015
Vibration-induced compaction of granular suspensionsS Kiesgen de Richter, C Hanotin, P Marchal, et al.Revue Medicale Suisse|September 16, 2006
[Rimonabant improves cardiometabolic risk profile in obese or overweight subjects: overview of RIO studies]A J Scheen, L G Van Gaal, J P Després, et al.Pageof 1